United States Federal Circuit

In an interference between patent applications involving a vaccine, a decision awarding priority to appellees is reversed and remanded where, based on the constructive reduction to practice of an invention whose disclosure was in compliance with the requirements of 35 U.S.C. section 112, appellants were entitled to the priority benefit of an Australian filing date, which predated appellees' earliest date.

Appellate Information

• Decided 08/20/2007
• Published 08/20/2007

Judges

Court

• United States Federal Circuit

Counsel